You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 6, 2025

Details for Patent: 9,381,179


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,381,179
Title:Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
Abstract: Dermatological disorders having an inflammatory or proliferative component are treated with pharmaceutical compositions containing on the order of 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthanoic acid (adapalene) or salt thereof, formulated into pharmaceutically acceptable media therefor, advantageously topically applicable gels, creams or lotions.
Inventor(s): Graeber; Michael (Lawrenceville, NJ), Czernielewski; Janusz (Biot, FR)
Assignee: GALDERMA RESEARCH & DEVELOPMENT (Biot, FR)
Application Number:14/222,185
Patent Claim Types:
see list of patent claims
Use; Composition;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a U.S. Patent: A Detailed Analysis of United States Patent 9,381,179

Introduction

When analyzing a U.S. patent, it is crucial to understand the various components that define its scope and protection. This article will delve into the specifics of United States Patent 9,381,179, using it as a case study to explain the key elements of a patent, particularly focusing on the scope and claims.

Patent Structure Overview

A U.S. patent is divided into several sections, each serving a distinct purpose.

Document Number and Type

The document number, often prefixed with "US" and followed by a code like "B2," indicates that it is a U.S. patent with a previously published application[1].

Title and Abstract

The title of the invention is limited to 500 characters or less and provides a concise description of the patent. The abstract is a brief summary of the invention, helping readers quickly understand its essence[1].

Background and Summary of the Invention

This section discusses the related prior art, explaining how the current invention improves upon or differs from existing technologies. It also provides a summary of the invention, outlining its main features and objectives[1].

Detailed Description of the Invention

The specification is a written description of the invention, including a discussion of the related prior art, a description of the drawings, how the invention solves a specific technical problem, and the preferred embodiment of the invention. This section must be detailed enough for anyone with ordinary skill in the same technical field to understand and replicate the invention[1].

Drawings and Figures

The drawings section contains black and white drawings that illustrate the technical details of the invention. These visual aids are crucial for understanding the structural and functional aspects of the patented technology[1].

Claims

Definition and Purpose

The claims are paragraphs located at the end of the specification and define the scope of protection for the patent. They are preceded by phrases like “I claim” or “What is claimed” and are numbered. The claims legally define the boundaries of the invention, similar to how a property deed defines physical boundaries[1].

Types of Claims

  • Independent Claims: These claims stand alone and do not depend on other claims. The initial patent application filing fee in the U.S. covers up to 3 independent claims and a total of 20 claims[2].
  • Dependent Claims: These claims refer back to and further limit an independent claim. They are used to add specific details or variations to the independent claims[2].

Strategic Claim Management

Effective claim management is critical for maximizing the value of a patent. This involves strategically composing and adjusting claims during the patent prosecution phase to align with USPTO requirements. Adding new dependent claims for every canceled claim ensures that the patent utilizes its full quota of claims, enhancing its breadth and flexibility without additional costs[2].

Patent 9,381,179: A Case Study

Title and Abstract

To analyze Patent 9,381,179, start by reviewing its title and abstract. These sections provide an initial understanding of the invention's purpose and main features.

Background and Summary

The background section will discuss prior art and how the invention addresses existing technical problems. The summary will outline the key improvements and innovations introduced by the patent.

Detailed Description

The detailed description will include a thorough explanation of the invention, its components, and how it operates. This section is crucial for understanding the technical aspects and the preferred embodiment of the invention.

Drawings and Figures

Review the drawings to visualize the invention's structure and functionality. These visual aids are essential for a comprehensive understanding.

Claims Analysis

  • Independent Claims: Identify the independent claims, which define the broadest scope of the invention.
  • Dependent Claims: Analyze the dependent claims to understand the specific variations and details of the invention.
  • Claim Management: Determine if the patent has been optimized for claim management. Check if the full quota of claims has been utilized and if the claims have been strategically adjusted during the prosecution phase[2].

Determining Inventorship

Inventorship is determined by identifying who conceived the subject matter of at least one claim of the patent. This involves focusing on the conception step, where the idea of the complete and operative invention was formed in the mind of the inventor. Only those who conceived the idea or collaborated to produce the invention are considered inventors[4].

Patent Landscape and Scope

IPC and National Classification

The International Patent Classification (IPC) and national classification codes provide insight into the broader technological field in which the patent resides. For example, the national classification code H04M 1/0235 indicates that the patent is related to slidable or telescoping telephones[1].

References and Prior Art

The references section lists U.S. and foreign patent documents and other publications cited as related prior art by the inventor and patent examiner. This helps in understanding the context and novelty of the invention[1].

Economic and Strategic Implications

The strategic management of claims can significantly impact the patent's value. By ensuring that the patent utilizes its full complement of claims, inventors can secure robust and nuanced protection, enhancing the patent's defensive capabilities and its value in licensing discussions or infringement disputes[2].

Case Law and Regulatory Considerations

Reissue claims, for instance, must comply with 35 U.S.C. § 251, which requires that the reissue claims be directed to the invention disclosed in the original patent. This ensures that the scope of the claims does not expand beyond what was originally disclosed[5].

Key Takeaways

  • Patent Structure: Understand the various sections of a U.S. patent, including the title, abstract, background, detailed description, drawings, and claims.
  • Claims Management: Effective claim management is crucial for maximizing the value of a patent. This includes strategically composing and adjusting claims during the patent prosecution phase.
  • Inventorship: Determine inventorship by identifying who conceived the subject matter of at least one claim of the patent.
  • Patent Landscape: Analyze the IPC and national classification codes, references, and prior art to understand the broader technological context.
  • Regulatory Compliance: Ensure that any reissue claims comply with relevant statutes and regulations.

FAQs

What is the purpose of the claims section in a U.S. patent?

The claims section defines the scope of protection for the patent, legally outlining what is protected by the patent.

How many claims can be included in a U.S. patent application?

The initial patent application filing fee covers up to 3 independent claims and a total of 20 claims.

Why is strategic claim management important?

Strategic claim management ensures that the patent utilizes its full quota of claims, enhancing its breadth and flexibility without additional costs, and maximizing its defensive capabilities and value.

Who is considered an inventor in a U.S. patent?

An inventor is a person who conceives the subject matter of at least one claim of the patent or collaborates with others to produce the invention.

What are the requirements for reissue claims under U.S. patent law?

Reissue claims must be directed to the invention disclosed in the original patent, as required by 35 U.S.C. § 251.

Sources

  1. How to Read a U.S. Patent - Patents and Designs - Research Guides[1]
  2. Maximizing Patent Value: A Strategic Approach to Claim Management - Harrity & Harrity, LLP[2]
  3. Patent Claims Research Dataset - USPTO[3]
  4. Determining Inventorship for US Patent Applications - Oregon State University[4]
  5. In Re FLOAT'N'GRILL LLC - Court of Appeals for the Federal Circuit[5]

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,381,179

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 9,381,179

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
France02 03070Mar 12, 2002

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.